What You Should Know:
– Switchboard Health, a creator of a digital health platform for connecting patients with high-value specialty care, has announced the acquisition of Conduce Health. Financial details of the acquisition were not disclosed.
– Conduce Health is an AI-driven solution specializing in personalized multispecialty care. This strategic acquisition will combine Switchboard’s existing EMR-integrated software and virtual care network with Conduce’s predictive analytics and clinical decision support technology. The overarching goal is to match patients with the best-fit specialists more effectively.
Integrating AI for Proactive and Predictive Specialty Care
Conduce Health, founded in 2023, developed an AI platform designed to make specialty care proactive, predictive, and personalized. Its software empowers clinical teams to refer patients to optimal specialists based on nuanced clinical and personal variables.
Through the acquisition, Switchboard Health will integrate Conduce’s advanced AI capabilities, including:
- Predictive models for disease progression and urgent medical needs.
- Precision patient-specialist matching.
These enhancements will be integrated into Switchboard’s existing referral management, care navigation, and virtual care capabilities to more effectively connect clients to high-value specialists. Key Conduce team members will also join Switchboard.
“We founded Conduce to ensure patients receive personalized, multispecialty care the first time, every time,” said Najib Jai, MD, co-founder and CEO of Conduce Health. “We’re excited to see Switchboard integrate Conduce’s technology into its referral and care navigation workflows to advance that mission and deliver high-value specialty care at scale.”
